fbpx

UrgoTul Absord

ABSORBENT LIPIDO-COLLOID FOAM DRESSING

UrgoTul Absorb is a soft-adherent foam dressing with TLC, comprised of:

  • A soft-adherent TLC layer combined with an absorbent polyurethane foam pad
  • A protective non-woven polyurethane backing.
MODE OF ACTION

When in contact with wound exudate, UrgoTul Absorb gels and creates a moist environment, promoting healing. UrgoTul Absorb stimulates fibroblast proliferation and ensures non-adherence and pain-free dressing changes.
The absorbent polyurethane foam pad ensures drainage of exudate, protecting the peri-wound skin against maceration.

BENEFITS FOR THE WOUND
  • Optimal wound healing
  • Epidermal regeneration
  • Moist wound healing
  • Moderate to high absorbency
  • Fibroblast proliferation
  • No adherence to the wound (no damage to newly formed tissue)
  • Protection and improvement of surrounding skin
  • Can be left in place for up to 7 days* – fewer dressing changes reducing healing disturbance
  • High conformability to the wound bed
BENEFITS FOR HEALTH PROFESSIONALS
  • Optimal reconstruction of dermis and epidermis
  • Easy to apply
    • Stays in place when applied
    • Easy to reposition without losing its gentle adherence
  • Easy to remove with pain-free dressing change
  • Exudate management (moderate to high absorbency)
  • Can be left in place for up to 7 days* – fewer dressing changes
  • Improved patient quality of life
  • Can be used under compression
  • Efficacy clinically proven
INDICATIONS

UrgoTul Lite is indicated for the treatment of low to moderately exuding wounds in the epithelialisation stage (chronic wounds such as pressure ulcers, leg ulcers, diabetic foot ulcers, and acute wounds such as 2nd degree burns, skin abrasions, traumatic wounds, post-operative wounds) and for the local treatment of fungating wounds in combination with a specific treatment.

Due to the non-adhesive nature of the dressing, UrgoTul Lite is recommended in the treatment of wounds in which the surrounding skin is weakened.

CONTRAINDICATIONS

None